These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000957-47 Comparison of Bisoprolol and Carvedilol in elderly patients with heart failure. A randomised doubleblind multicenter trial 2008-07-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-002420-18 A prospective, non-randomised, non-controlled, open label, multicentre phase II study: PTK 787/ZK222584 in patients with advanced neuroendocrine tumours 2005-04-29 bad-data
Exempt, with results 2004-002646-35 Pilot study for evaluation of growth factor erythropoietin beta for improvement of left ventricular function after coronary interventions 2008-10-31 not-yet-due
Reported results 2004-003816-47 Clinical pilot study on the effect of Metformin in adipose children and adolescents with insulin-resistance Klinische Pilotstudie zur Untersuchung der Wirkung von Metformin bei adipösen Kindern und J... 2007-08-01 due-trials
Reported results 2004-004352-40 Einfluss einer präoperativen Vakzinierung auf das Immunsystem und die postoperative Infektionsrate 2009-07-13 due-trials
Reported results 2004-005172-17 Renal haemodynamics during application of contrast media in patients undergoing cardiac catheterisation with high risk of acute renal failure: randomized comparison of different contrast media 2008-07-16 due-trials
Reported results 2005-001456-20 „Pilotstudie zum Einfluss selektiver neurogener Blockaden auf die perioperative Immunreaktion bei Lungen-resezierten Patienten.“ 2008-07-10 due-trials
Reported results 2005-001486-33 Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome [Sicherheit und Wirksamkeit von Levetiracetam (Keppra) für die Behandlung des stationären Alkoholentzugsy... 2008-06-18 due-trials
Reported results 2005-001559-39 Randomisierte Phase II Studie zum Vergleich einer wöchentlichen Topotecangabe mit der Topotecangabe an fünf aufeinander folgenden Tagen bei Patientinnen mit platinresistentem rezidiviertem epitheliale... 2013-01-10 due-trials
Reported results 2005-001602-76 Phase III clinical trial comparing treatments of hormone-refractory prostate cancer (HRPC) with Docetaxel: continuous treatment vs. intermittent repetition of treatment after progression. 2010-08-03 due-trials
Reported results Terminated 2005-001907-21 A randomised, double-blinded, multicenter, parallel group study comparing a remifentanil-regimen with a fentanyl-regimen for analgesia in mechanically ventilated patients 2009-06-05 due-trials
Reported results 2005-002320-34 Randomized controlled 12 months trial with etanercept (enbrel ®) vs. sulfasalazine followed by an open-label extension with etanercept up to week 540 in early axial spondyloarthritis with focus on imp... 2018-02-01 due-trials
Reported results Terminated 2005-002475-32 Pilotstudy about endocrinilogical, peripherphysilogical and painreducing effects of Gamma-hydroxybutyrate in combination with operant-behaviour-therapeutic paintherapy with patients in Fibromyalgia-Sy... 2011-11-21 due-trials
Reported results 2005-002582-37 Characterization of protective effects of a piperidine derivative (DPMP, 4-diphenylmethoxy-1 [3-(4-ter-butylbenzoyl)-propyl] piperidine) on cognitive impairment in urticaria patients 2006-04-21 due-trials
Reported results 2005-003195-38 Randomized double-blind placebo-controlled and parallel group study to evaluate the impact of one year therapy with monthly oral ibandronate 150 mg on structural properties of bone in postmenopausal ... 2007-10-11 due-trials
Reported results 2005-003488-22 Regulation des Antidiuretisches Hormons (ADH) und der antidiuretischen Wirkung unter Glucocorticoid - Therapie 2007-05-31 due-trials
Reported results 2005-003617-33 A Randomised Cross-Over Study to Explore the Pathophysiological Mechanisms Involved in the Treatment of Actinic Keratoses with Solaraze 2006-12-31 due-trials
Reported results Terminated 2005-003648-70 Randomised, double-blinded phase IIIb study to optimise antiviral therapy response of a standard therapy consisting of peginterferon-alfa-2a and ribavirin plus the additional use of bezafibrat 400 mg/... 2011-10-04 due-trials
Reported results 2005-003714-15 Mechanismen der Glukagon-induzierten Stimulation des Wachstumshormons; die Rolle des Glukagons in der Ghrelin-Regulation 2012-06-01 due-trials
Reported results 2005-005017-38 Efficacy of cetuximab in combination with docetaxel for the treatment of relapsed head and neck carcinoma: A clinical phase II trial 2008-11-01 due-trials
Reported results 2005-005021-60 Monozentrische, randomisierte, einfach verblindete, Placebo kontrollierte Studie im Cross over Design zur Untersuchung der Wirkung von Telmisartan (Kinzalmono 80 mg) auf Blutdruck und Endothelfunktion... 2010-04-30 due-trials
Reported results 2005-006133-32 An exploratory phase IV, randomised, double-blind, placebo controlled crossover study to assess and compare the effects of 5 mg vs. 20 mg Desloratadine on the development of experimentally induced urt... 2006-05-11 due-trials
Reported results Terminated 2006-000815-24 A randomized study of topical 3% Diclofenac in a 2.5% Hyaluronate base (Solaraze® 3% Gel) versus topical 5% 5-Fluorouracil (Efudix® Cream) versus liquid nitrogen spray cryotherapy in immunosufficient ... 2006-10-31 due-trials
Ongoing 2006-001269-40 Induction of Tolerance with Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Severe Systemic Lupus Erythematosus (SLE) Refractory to Standard Immunosuppressive Thera... not-yet-due
Reported results 2006-001528-38 Prevention of skin cancer in high risk patients after conversion a to Sirolimus-based immunosuppressive 2011-04-19 due-trials
Reported results 2006-002306-64 Open label clinical trial with Rituximab (MabThera ®) in Ankylosing Spondylitis - Extension of open label trial: Re-Treatment of patients who have shown response to first course of Rituximab 2007-07-10 due-trials
Reported results 2006-003146-41 A CONTROLLED RANDOMIZED DOUBLE-BLIND MULTICENTER STUDY COMPARING TWO THERAPY STRATEGIES IN DMARD-NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS OVER 48 WEEKS: INDUCTION THERAPY WITH ADALIMUMAB AND METHOTRE... 2011-04-28 due-trials
Reported results 2006-003470-10 Randomised Phase II study with non-pegylated liposomal Doxorubicin (Myocet) plus Ifosfamid versus Doxorubicin plus Ifosfamid in the first-line treatment of locally advanced or metastatic soft tissue c... 2013-06-06 due-trials
Reported results 2006-003686-13 An exploratory phase III, randomised, double blind, therapeutic single dose-related effect, parallel group study to assess and compare the effects of 5mg vs. 20mg Desloratadine on skin lesions in pati... 2010-08-30 due-trials
Reported results 2006-003999-35 Efficacy and safety of levetiracetam in prevention of alcohol relapse in recently detoxified alcohol dependent patients 2009-12-31 due-trials
Reported results Terminated 2006-004162-13 Randomized, double-blind, placebo-controlled phase II pilot study of the impact of mesalazine enemas on the mucosal gut flora in patients with inflammatory bowel disease 2008-08-31 due-trials
Reported results 2006-004290-97 A Single-Centre, Open Label Study of the Safety and Tolerability of Rilonacept in Subjects Living in Germany with Muckle-Wells Syndrome (MWS), a Cryopyrin-Associated Periodic Syndrome, or Schnitzler’s... 2010-08-25 due-trials
Reported results 2006-004628-34 Topotecan plus Carboplatin im Vergleich zur Standardtherapie (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin oder pegyliertes liposomales Doxorubicin plus Carboplatin) in der Therapie vo... 2015-06-30 due-trials
Reported results 2006-004860-29 D-Cycloserine supported exposure in panic disorder 2010-01-31 due-trials
Reported results Terminated 2006-004891-10 Future strategies for vocational rehabilitation schizophrenia 2011-10-04 due-trials
Reported results 2006-005262-39 Flupirtin as Oral Treatment in MS 2012-11-26 due-trials
Reported results Terminated 2006-005710-12 Evaluation of the effect of NICOtinic acid (niacin) on elevated Lipoprotein(a) levels (NICOLa Study) 2010-02-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005778-34 Multicenter European pilot study of 90Yttrium-ibritumomab tiuxetan as first line therapy for stage III – IV follicular lymphoma (and selected patients with extended stage II) followed by consolidatio... 2015-06-30 bad-data
Reported results 2006-006088-22 Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carcinom... 2021-06-09 due-trials
Reported results 2006-006323-39 Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis 2012-11-06 due-trials
Reported results 2006-006516-30 Combined systemic an intrathecal chemotherapy with succeeding high dosis chemotherapy and autologous stem cell transplantation of patients with CNS relapses of agressive lymphomas. 2012-01-02 due-trials
Exempt, with results Terminated 2006-006962-41 Dendritic cells as autologous vaccine in patients with chronic myeloid leukemia 2020-04-30 not-yet-due
Reported results 2007-000512-82 Optimal Duration of Olazapine Add-on therapy in Major Depression: A double-blind, placebo-controlled, randomized, Phase III, Pilot Study in parallel group Design 2008-03-28 due-trials
Reported results 2007-000579-40 Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study 2012-12-31 due-trials
Reported results 2007-000718-35 CONKO-006 Additive Therapie beim R1-resezierten Pankreaskarzinom mit Gemcitabin plus Sorafenib versus Gemcitabin plus Placebo über 12 Monate - eine doppelblinde, placebokontrollierte Phase IIb Studie 2017-08-31 due-trials
Reported results 2007-001677-28 Evaluation de l’effet anesthésique du protoxyde d’azote dans une population d’opérés recevant une anesthésie totale intraveineuse en « boucle » guidée par l’index bispectral (Effect of nitrous oxide o... 2009-01-30 due-trials
Reported results Terminated 2007-001787-71 The influence of Rimonabant induced cannabinoid receptor blocking on the mass and function of the left ventricle in patients with abdominal adiposity 2008-12-12 due-trials
Reported results Terminated 2007-002023-32 Niaspan for the treatment of endothelial dysfunction in patients without hyperlipoproteinemia 2013-02-18 due-trials
Reported results 2007-002223-32 A multicentre, double-blind, randomised controlled trial of sodium bicarbonate to prevent acute kidney injury in patients undergoing cardiopulmonary bypass surgery. 2011-11-26 due-trials
Reported results 2007-002967-28 Pilot open label clinical trial with Abatacept in Ankylosing Spondylitis 2011-05-01 due-trials
Reported results 2007-003111-31 Influence of postoperative influenza vaccination versus GM-CSF in immune-compromised patients undergoing pancreatic or esophageal resection on the course of immunosuppression and the postoperative inf... 2011-09-30 due-trials
Ongoing 2007-003370-26 A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man not-yet-due
Reported results Terminated 2007-003642-15 A Randomized, Double-blind Superiority Trial to Evaluate the Safety, Tolerability, and Efficacy of Belimumab in Refractory ITP Subjects 2008-11-03 due-trials
Reported results Terminated 2007-003775-39 Randomised, placebo-controlled parallel-group trial to evaluate an oral dose of 10 mg Olanzapin combined with Riluzol for the treatment of appetite loss on patients with amyotrophic lateral sklerosis 2012-07-10 due-trials
Reported results 2007-003813-15 CONKO-005: Adjuvante Therapie des R0-resezierten Pankreaskarzinoms mit Gemcitabin plus Erlotinib versus Gemcitabin über 24 Wochen – eine prospektive, randomisierte, Phase III Studie 2016-10-31 due-trials
Reported results 2007-004134-16 Effectiveness and Safety of Pregabalin (Lyrica) in treatment of in-patients with ethanol withdrawal syndrom 2011-06-17 due-trials
Reported results Terminated 2007-004150-85 Cardiac failure with normal ejection fraction: possible role of phosphodiesterase type 5 inhibitors 2010-02-23 due-trials
Reported results 2007-004401-10 Hydrocortisone for Prevention of Septic Shock Placebo-controlled, randomised, double-blind study to investigate the efficacy and safety of low dose hydrocortisone to prevent the development of septic... 2015-01-29 due-trials
Reported results Terminated 2007-004674-49 Levosimendan vor Herz-Lungen-Maschine bei Coronary artery bypass graft-Operationen 2010-08-18 due-trials
Reported results 2007-005475-34 Prospektive Studie zur potentiellen Protektion der Ovarfunktion von Frauen mit gynäkologischen Malignomen unter Chemotherapie mittels GnRH-Analoga-Applikation 2013-03-18 due-trials
Reported results Terminated 2007-006126-10 pilot study to evaluate the efficacy of Efalizumab in patients with cutaneous t-cell lymphoma 2011-03-11 due-trials
Reported results 2007-006438-33 Influence of I(f) blockade on orthostatic tolerance and sympathic activity in healthy subjects. 2011-08-23 due-trials
Reported results 2007-007011-85 Topical application of morphine for wound healing and analgesia in patients with painful oral lesions 2012-12-31 due-trials
Completed, but no date, and reported results 2007-007034-18 Phase II-Studie zur Erfassung der Effektivität einer wöchentlich verabreichten Docetaxel-Carboplatin/Cisplatin-Cetuximab-Kombination (DCC) bei fortgeschrittenen Plattenepithelkarzinomen des Oropharynx... bad-data
Reported results 2007-007637-39 Effects of NSAIDs on RAdiographic Damage in AS (ENRADAS) – a prospective randomised controlled trial - Amendment 2 2014-01-09 due-trials
Reported results 2007-007657-31 Efficacy and safety of Miltefosine in antihistamine resistant chronic urticaria 2010-04-30 due-trials
Reported results Terminated 2008-000247-34 Prospektive randomisierte Phase II/III-Studie zur selektiven COX-2-Inhibition beim chronischen Subduralhämatom (Prospective randomized phase II/III study for the selective COX-2-inhibition in chronic ... 2010-04-28 due-trials
Reported results Terminated 2008-000653-36 Efficacy and tolerability of Docetaxel-Gemcitabin in patients with advanced non-small cell lung cancer and an ECOG-Performance-Index of 2. A multicenter phase II-trial. 2010-07-08 due-trials
Reported results 2008-001770-33 INVESTIGATOR-INITIATED SINGLE BLIND, TWO-ARMED, RANDOMIZED PHASE 3 CLINICAL TRIAL TO COMPARE EFFICACY OF 5% MINOXIDIL TOPICAL FOAM (5% MTF) ONCE DAILY VERSUS 2% MINOXIDIL TOPICAL SOLUTION (2% MTS) TWI... 2009-02-28 due-trials
Reported results Terminated 2008-001849-26 Multicentre, open phase II trial to evaluate safety and efficacy of a perioperative chemotherapy with docetaxel, cisplatin and capecitabin in patients suffering from adenocarcinoma of the stomach, gas... 2012-03-15 due-trials
Reported results 2008-002226-11 Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients 2020-10-23 due-trials
Reported results 2008-003256-29 Effect of Methylnaltrexone on Postoperative Analgesic Demands 2012-11-24 due-trials
Reported results 2008-003951-54 Intraveneous induction theraphy followed by oral theraphy against exclusive oral theraphy: randomized trial for the treatment of Whipple's disease 2020-11-05 due-trials
Reported results 2008-004182-26 Antidepressive efficacy, safety, tolerability and genetic response predictors of lithium augmentation in Escitalopram-treated patients with major depression 2012-08-03 due-trials
Reported results 2008-005167-33 Effect of gabapentine as symptomatic therapy for cerebellar ataxia in degenerative and inflammatory CNS-disease 2016-03-31 due-trials
Reported results 2008-005213-22 SUPREMES - Sunphenon in progressive forms of multiple sclerosis 2016-02-29 due-trials
Reported results Terminated 2008-005451-23 Vergleichende, randomisierte, kontrollierte und doppelblinde In-situ-Studie zur Wirkung von Speichelersatzmitteln auf Schmelz und Dentin 2011-10-31 due-trials
Reported results 2008-005746-22 Multi-center, double blind, dose escalating study to compare the effects of 5 mg, 10mg and 20mg of Desloratadine in patients with acquired cold urticaria (ACU) 2010-04-28 due-trials
Reported results Terminated 2008-005786-60 A prospective, multicentre trial on the value of 18F-FET PET in the post-therapeutic evaluation of childhood brain tumours 2018-11-20 due-trials
Exempt, with results Terminated 2008-006055-52 Everolimus (RAD001) in combination with intravenous carboplatin in taxane- and anthracycline-pretreated patients with progressive metastatic breast cancer 2014-11-04 not-yet-due
Reported results 2008-006135-12 Balanced crystalloids versus balanced colloids within a goal-directed hemodynamic protocol in patients undergoing gynaecological tumor resection. Balancierte Kristalloide versus balancierte Kolloide ... 2011-06-16 due-trials
Reported results Terminated 2008-007031-41 Beta-Blocker in Acute Ischemic Stroke – a prospective, randomized, double-blinded, placebo-controlled safety and efficacy trial of early treatment 2012-08-31 due-trials
Reported results Terminated 2008-007237-47 Perioperative physostigmine prophylaxis for liver resection patients at risk for delirium and postoperative cognitive dysfunction Perioperative Gabe von Physostigmin bei Leberteilresktion zur Prophyl... 2017-10-19 due-trials
Reported results Terminated 2008-008232-87 Open-label phase II study of sorafenib in patients with advanced hepatocellular carcinoma (HCC) and Child Pugh score B with special analysis of patients 65 years or older 2011-07-30 due-trials
Reported results 2008-008474-31 Nutzen des Placeboeffektes bei atopischer Dermatitis - Steigerung der pharmakologischen Wirkung bei Juckreiz durch Klassische Konditionierung und Erwartungsprozesse: Eine randomisierte kontrollierte S... 2014-03-16 due-trials
Reported results 2009-009476-12 Non-invasive detection of prostate cancer using functional MRI in patients with histopathologically confirmed prostate cancer before prostatectomy 2011-01-20 due-trials
Reported results Terminated 2009-009656-20 Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease 2015-02-13 due-trials
Exempt, with results 2009-009928-37 Phase 1/2 Studie: CONKO-008 Oxaliplatin/Folinsäure/5-Fluorouracil (24h) in Kombination mit Lapatinib in der Zweitlinientherapie des Pankreaskarzinoms nach Progress unter Gemcitabin-Monotherapie 2011-12-31 not-yet-due
Reported results 2009-011277-33 A therapy and pharmacokinetics study of temsirolimus in patients with refractory and recidivated primary CNS lymphoma 2014-12-15 due-trials
Reported results 2009-011922-33 A randomized, double-blind, placebo controlled, multicenter Phase II study to assess the efficacy and safety of Sorafenib added to standard treatment with Topotecan in patients with platinum-resistant... 2015-02-10 due-trials
Reported results 2009-013432-20 Intra-individual, randomized comparison of the MRI contrast agents gadobutrol versus gadoterate meglumine in breast MR imaging 2010-07-30 due-trials
Reported results 2009-013458-33 Modulation of Cytochrome-P450 dependent eicosanoid formation by treatment with omega-3 PUFA (Omacor®) 2010-12-31 due-trials
Reported results 2009-013976-38 Phase II Trial of low-dose Sandimmun Optoral ® (Cyclosporine A) for the treatment of primary Sjögren's syndrome (pSS) 2014-10-28 due-trials
Reported results Terminated 2009-014300-55 Phase II study on the combined systemic and intrathecal chemotherapy with methotrexate, ifosfamide and liposomal cytarabine (DepoCyte®) in patients with HER-2/neu-negative breast cancer and leptomenin... 2012-03-02 due-trials
Exempt, with results Terminated 2009-014844-13 Phase I/II clinical trial with Bendamustine and Temsirolimus in patients with relapsed or refractory mantle cell lymphoma that are not eligible for high dose chemotherapy and stem cell transplantation... 2011-03-17 not-yet-due
Reported results Terminated 2009-015319-41 Trichuris suis Oozyten (TSO®) in remittent-recurrent Multiple Sclerosis (MS) and Clinically Isolated Syndrom (CIS) Trichuris suis Oozyten (TSO®) bei schubförmig remittierender MS und CIS 2016-03-02 due-trials
Reported results 2009-016043-19 Impact of a balanced infusion solution compound of 50% cristalloid and 50% colloid versus a unbalanced infusion solution of 100% cristalloid within a goal-directed hemodynamic protocol on acid-base ba... 2011-11-14 due-trials
Reported results Terminated 2009-016482-28 SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy Sunphenon EGCg (Epigallocatechin-Gallat) in der Muskeldystrophie vom Typ Duchenne 2018-09-06 due-trials
Reported results 2009-016907-41 Investigation of nociceptive and antinociceptive mechanisms under anesthesia using fMRI, EEG and noxious reflexes Untersuchung von nozizeptiven und antinozizeptiven Mechanismen unter Narkose mittel... 2013-08-19 due-trials
Reported results Terminated 2009-017458-11 Homeopathy for Depression: a randomized, four-armed, partial double-blind study. 2011-07-22 due-trials
Reported results 2009-017581-22 Cognitive impairment in bipolar disorder treated with aripiprazole Kognitive Beeinträchtigung bei bipolarer Störung unter Behandlung von Aripiprazol 2013-12-31 due-trials
Reported results 2009-017739-17 Assessment of myocardial viability in MRI: Comparison of Late Gadolinium Enhancement with Gadovist vs. Magnevist vs. Dotarem 2010-12-09 due-trials
Reported results 2010-018291-25 INVESTIGATOR-INITIATED, DOUBLE BLIND, TWO-ARMED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL WITH AN OPEN-LABEL EXTENSION PHASE, TO INVESTIGATE EFFICACY OF 5% MINOXIDIL TOPICAL FOAM TWICE DAILY IN M... 2013-03-18 due-trials
Reported results 2010-019218-26 Offene Verträglichkeitsstudie zur Evaluierung einer subkutanen Injektionslösung von 100 mg Anakinra in Kombination mit Riluzol bei Patienten mit Amyotropher Lateralsklerose (ALS). 2013-05-31 due-trials
Reported results 2010-019344-39 Double-blind, triple cross-over, placebo-controlled study to assess the efficacy, mechanisms, and safety of treatment with bilastine 20 mg, 40 mg and 80 mg in cold contact urticaria (CCU) Compound: Bi... 2011-08-26 due-trials
Reported results 2010-019347-18 Randomized Phase II Study of two different Regimens of TPF Induction Chemotherapy Regimen followed by Radiation Therapy plus cetuximab (TPF-CET-HART) vs. HART and Cisplatinum, 5-FU (PF-HART) in Patien... 2015-04-28 due-trials
Reported results 2010-020063-21 “A 20-week open-label study to assess the efficacy and safety of single doses of Ilaris® (Canakinumab, ACZ885) in patients with active, refractory urticarial vasculitis” 2010-07-27 due-trials
Reported results Terminated 2010-020433-13 Eine 8-wöchige, monozentrische, baseline-kontrollierte offene Studie zur Evaluierung des Einflusses einer “Single pill combination” auf die Blutdrucksenkung bei Patienten mit nicht-kontrolliertem Blut... 2012-04-02 due-trials
Reported results 2010-020480-21 Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer 2021-04-21 due-trials
Reported results 2010-021001-21 An exploratory, randomised, double-blind, placebo controlled crossover study to assess the efficacy of 20 mg Rupatadine on the treatment of mastocytosis symptoms 2011-10-01 due-trials
Reported results 2010-021275-92 Single center, open-label, cross-over study in maintenace kidney allograft recipients to evaluate the bioavailability of CellCept® (Mycophenolate mofetil) in comparison to Myfortic® (Enteric- coated ... 2013-03-13 due-trials
Reported results Terminated 2010-021604-16 A double-blind, randomized, placebo controlled study to evaluate the effectiveness of etoricoxib as an additive analgesic to epidural analgesia in colon or rectum fast-track surgery 2014-04-25 due-trials
Reported results 2010-021775-80 Explorative Untersuchung zum Einfluss der Vitamin D-vermitteltenr Modulation der initialen subkutanen Gräserpollen-spezifischen Immuntherapie bei Allergikern mit Gräserpollen-induzierter Rhinokonjunkt... 2015-01-13 due-trials
Reported results 2010-021861-62 Baclofen for the Treatment of Alcohol Dependence 2014-05-20 due-trials
Reported results 2010-023044-32 Mechanisms of action in exposure therapy: Decoding the neural basis of fear extinction and its pharmacological modulation in patients with panic disorder 2014-03-31 due-trials
Reported results 2010-023941-31 Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington 2015-04-09 due-trials
Reported results 2010-024156-28 A multi-center, double-blind, placebo-controlled phase II study of the efficacy and safety of canakinumab in subjects with Schnitzler syndrome 2017-12-21 due-trials
Reported results 2010-024379-15 Pazopanib with 5-Flourouracil, Leucovorin and Oxaliplatin (FLO) as 1st-line treatment in advanced gastric cancer; a randomized Phase II study. - The PaFLO study. Pazopanib mit 5-FU, Leukovorin und ... 2015-11-19 due-trials
Exempt 2011-000259-17 A phase I/II study of Pazopanib and weekly Topotecan in patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer 2018-06-30 not-yet-due
Reported results 2011-000844-56 UsTekinumab for the treatment Of Patients with active Ankylosing Spondylitis (TOPAS) – a 28-week, prospective, open-label, proof-of-concept study 2013-05-07 due-trials
Reported results Terminated 2011-001027-20 A Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's disease (AOSD) including an open-label long term extension. Eine multizentrische, Plazebo-k... 2018-05-04 due-trials
Reported results 2011-001232-27 Characterization of human peripheral and intestinal T-cell responses after mucosal antigen exposure: induction of tolerance vs. immunization by oral administration of KLH 2015-06-30 due-trials
Reported results 2011-001398-19 D-cycloserine augmented exposure therapy in patients with agoraphobia 2014-04-25 due-trials
Reported results Terminated 2011-001403-12 Carbon Dioxide for the Treatment of Febrile Seizures 2015-06-30 due-trials
Reported results Terminated 2011-001474-25 A single-centre, single arm, open-label, exploratory trial of Interleukin-2 administered subcutaneously as neo-adjuvant treatment prior to sentinel lymph node biopsy(SLNB)/complete lymph node dissecti... 2019-12-31 due-trials
Reported results 2011-001689-16 Prospective randomized, double-blind, and placebo-controlled clinical trial with hydroxychloroquine (HCQ) in patients with erosive-inflammatory osteoarthritis (OA) of the finger joints (acronym: OA TR... 2018-07-05 due-trials
Reported results Terminated 2011-002785-20 Efficacy of Vitamin D Supplementation in relapsing-remitting Multiple Sclerosis 2017-06-26 due-trials
Reported results Terminated 2011-003746-41 A two-center, double blind, placebo-controlled study in parallel design to assess the efficacy and safety of 150 and 300 mg omalizumab in subjects with antihistamine-resistant cold contact urticaria (... 2015-02-11 due-trials
Reported results 2011-004094-93 Double-blind, three-way cross-over, placebo controlled study to assess the efficacy, safety and mechanisms of treatment with rupatadine 20 and 40 mg in cold contact urticaria (CCU) Función de la li... 2013-07-02 due-trials
Reported results 2011-004393-28 "Effectiveness of leech therapy in treatment of chronic low back pain - a randomised controlled clinical study" „Randomisierte kontrollierte Studie zur Wirksamkeit der Blutegeltherapie (Hirudo ve... 2017-12-31 due-trials
Reported results Terminated 2011-004463-69 Investigation of Radiation Retinopathy (RadiRet Study) Subtitle: Influence of Lucentis® on radiation retinopathy after irradiation of choroidal melanoma 2016-12-02 due-trials
Reported results Terminated 2011-004585-15 Single –arm, multicenter phase-II trial for catumaxomab and chemotherapy in patients with recurrent ovarian cancer to investigate the feasibility and clinical activity of initial intraperitoneal catum... 2014-02-25 due-trials
Reported results Terminated 2011-004787-30 Modification of the visual outcome after optic neuritis in CIS or MS by Gilenya® Modifizierung des visuellen Outcome nach Optikusneuritis in CIS oder MS durch Gilenya®: Eine prospektive, stratifizi... 2016-04-04 due-trials
Reported results Terminated 2011-004944-23 Prospektive open-label, multizentrische Phase IV Studie zur leberfunktionsangepassten Tacrolimus-Therapie nach Lebertransplantation (GRAFTT) 2014-05-01 due-trials
Reported results 2011-005615-87 A multicenter, randomized, double-blind, placebo-controlled 12-week, parallel-group study with a 6 week follow up period to demonstrate efficacy and safety of subcutaneous Omalizumab in patients with ... 2015-03-25 due-trials
Reported results 2012-000188-25 Lormetazepam versus Midazolam used as sedatives for critically ill patients. Lormetazepam versus Midazolam als Basissedativum für intensivpflichtige Patienten Multizentrische, randomisierte, kont... 2020-03-12 due-trials
Reported results 2012-000411-91 Monitoring natural killer cells in multiple sclerosis patients treated with fingolimod: a monocentric, prospective, one year, baseline-to-treatment, open-label, single group pilot trial Untersuchu... 2018-08-03 due-trials
Reported results Terminated 2012-000443-27 Determination of the penetration of antibiotics into epithelial lining fluid during continuous infusion in mechanically ventilated ICU patients: example meropenem 2012-08-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-000793-30 International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 2023-07-31 bad-data
Ongoing 2012-000810-12 IntReALL HR 2010 International Study for Treatment of High Risk Childhood Relapsed ALL 2010 not-yet-due
Completed, report not yet due Terminated 2012-001209-26 Efficacy of Tranylcypromine (TCP) in daily doses up to 60mg and lithiumaugmentation (Li.-Aug.) of antidepressants inn the acute treatmet of therapy-resistant Depression. An open randomized study in a ... 2024-02-23 not-yet-due
Reported results 2012-003217-33 Immunological response of a single dose of 100,000 I.U. of cholecalciferol (vitamin D3) Immunologische Wirkungen einer Einmalgabe von 100.000 I.E. Cholecalciferol (Vitamin D3) 2013-05-15 due-trials
Reported results 2012-003621-21 Prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled, aerosolized Tobramycin (TOBI®) b.i.d. in patients with vent... 2019-07-30 due-trials
Reported results 2012-003882-17 Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy subjects: a randomized, placebo-controlled, double-blind fMRI study. Effekte von... 2014-03-31 due-trials
Reported results Terminated 2012-003943-32 Influence of diabetes control on treatment of diabetic macular edema with ranibizumab Einfluss eines Diabetes-Managements auf die Behandlung des diabetischen Makulaödems mit Ranibizumab 2018-08-05 due-trials
Reported results Terminated 2012-004111-32 Prospective, open-label, multicentre study on the incidence of Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipients treated with per protocol, cyclic field application of... 2014-05-30 due-trials
Reported results 2012-005652-42 Biomarkers Of The Humoral Immune Response After Conversion To Belatacept In Comparison To Conventional Immunosuppressive Therapy In Renal Transplant Patients 2016-03-10 due-trials
Reported results 2012-005726-30 A multi-center, double-blind placebo-controlled parallel group phase II study of the efficacy and safety of rilonacept in subjects with cold contact urticaria (CCU) 2018-03-14 due-trials
Reported results 2013-000416-24 THE EFFECT OF AZELAIC ACID ON SYMPTOMS OF ACNE IN FEMALE PATIENTS AGE 20-45 WITH MILD TO MODERATE PAPULOPUSTULAR ACNE (ACNE TARDA) 2014-09-04 due-trials
Reported results 2013-000823-15 Neuroprotection with Dexmedetomidine in patients undergoing elective cardiac or abdominal surgery Neuroprotektion durch Dexmedetomidin bei Patienten mit kardio- oder abdominalchirurgischen Eingriff... 2018-07-31 due-trials
Exempt, with results 2013-001294-24 The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation – Natural regulatory T-cells (nTregs) Trial. Die ONE-Studie: Ein einheitlicher Ansatz zur Bewer... 2017-11-11 not-yet-due
Exempt, with results 2013-001599-40 Evaluation of the safety, tolerability, efficacy and immunological responses of the interleukin-2 analogue Aldesleukin (Proleukin®) in the treatment of systemic lupus erythematosus as prototypic autoi... 2018-10-19 not-yet-due
Reported results 2013-002409-75 Intra-individual, comparison of the MRI contrast agents gadoxetic acid (Primovist®) versus gadoterate meglumine (Dotarem®) in liver MRI of patients with HCC and underlying cirrhosis Intraindividuel... 2018-04-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-003542-17 A multi-center, randomized, double blind, dose escalating phase III study on the efficacy, safety and long term outcome of continuous vs. on demand treatment of chronic spontaneous urticaria with rupa... 2020-11-20 bad-data
Reported results Terminated 2013-003601-25 A multicenter, Double-blind, RandOmised, two arm Parallel group trial to determine the effects of torasemide versus furosemide on one marker (PIP) of cardiac fibrosis in patient with Diastolic Heart F... 2016-11-01 due-trials
Reported results 2013-004130-15 Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopecia Investigator... 2014-09-29 due-trials
Reported results Terminated 2013-005362-19 Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB) Therapie antikörper-vermittelter Autoimmunerkrankungen durch Bortezomib (TAVAB) 2021-08-30 due-trials
Ongoing 2014-000097-19 Open, comparative, randomized study on the efficacy, safety and bioavailability of highly concentrated inhaled epinephrine (4 mg L-epinephrine / ml, Infectokrupp® Inhal) versus epinephrine autoinjecto... not-yet-due
Reported results 2014-000181-21 Disease activity controlled dose escalating study to assess the efficacy, and safety of treatment with bilastine 20 mg, 40 mg and 80 mg in chronic spontaneous urticaria. Krankheitsaktivitätsgesteu... 2016-03-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-001325-33 Prospective donor-specific Cellular alloresponse assessment for Immunosuppression Minimization in de novo renal transplantation 2020-10-31 bad-data
Reported results 2014-001551-22 Reduction of postoperative wound infections by antiseptica 2018-10-20 due-trials
Reported results 2014-002392-28 Setmelanotide (RM-493) Treatment Trial in Patients with rare genetic disorders of obesity 2020-12-17 due-trials
Ongoing 2014-002439-32 A Randomized Phase II Trial of Transarterial Radioembolization with Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolization with Cisplatin (TACE) in Patients with Liver Metastases from Uvea... not-yet-due
Listed as ongoing, but also has a completion date 2014-002643-18 REDUCE - Multicenter, prospective, randomized study investigating the efficacy and safety of a reduced immunosuppressive therapy with tacrolimus once daily in comparison to standard triple immunosuppr... 2023-09-08 bad-data
Exempt Terminated 2014-003457-34 Safety of autologous CardAP-cells in patients with dilatative cardiomyopathy: an open, monocentric, double-arm, 3+3 dose escalation, phase I/II study Sicherheit autologer CardAP-Zellen in Patienten... not-yet-due
Reported results 2014-004551-32 Daclatasvir plus Sofosbuvir for chronic HCV-infected renal transplant patients – a pilot study of efficacy and safety 2017-03-22 due-trials
Reported results 2014-005239-15 Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors? Effekte der Min... 2019-02-11 due-trials
Reported results 2014-005344-17 Oral cannabidivarin (CBDV) solution for treatment of HIV-associated neuropathic pain – a randomized, double-blind, placebo-controlled phase II study. Orale Cannabidivarin (CBDV) Lösung zur Behandlu... 2020-01-15 due-trials
Reported results Terminated 2015-000465-31 Cannabidiol in Bipolar Depression – CannaBiD-Study: An 8-week randomized, double-blind, placebo-controlled clinical trial of Cannabidiol as add-on therapy in bipolar depression Cannabidiol in bipol... 2019-11-25 due-trials
Reported results 2015-000538-31 NEUORIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the knee joint NEUORIMPA - Intraartikuläre Applikation von Opioiden bei chronischer Arthritis des Kniegelenks 2021-08-27 due-trials
Reported results 2015-001456-29 A Double-blind, Placebo-controlled, Randomized, Multicenter Proof-of-principle Trial of Adjunctive Minocycline for Patients With Treatment Resistant Unipolar Major Depressive Disorder (MDD) Eine d... 2020-08-07 due-trials
Listed as ongoing, but also has a completion date 2015-003429-32 “Ibrutinib (Imbruvica®), Bortezomib (Velcade®) s.c., Rituximab, CHOP for the treatment of elderly patients (age 61-80 years) with CD20+ diffuse large B-cell lymphoma, IPI ≥ 2” „Eine Phase-I/II-Stud... 2024-11-12 bad-data
Ongoing 2015-004172-30 Prevention of paclitaxel-related neurological side effects with lithium – a randomized, double-blind, placebo-controlled, explorative proof-of-concept phase II clinical trial to counteract chemotherap... not-yet-due
Reported results 2015-005346-58 Tacrolimus after rATG and infliximab induction immunosuppression Tacrolimus después de inmunodepresión por inducción con rATG e infliximab- 2020-12-31 due-trials
Completed, reported early Terminated 2015-005757-12 Effect of IV iron (ferric carboxymaltose, Ferinject) on exercise tolerance, symptoms and quality of life in patients with heart failure with preserved ejection fraction (HFpEF) and iron deficiency wit... 2023-12-30 not-yet-due
Reported results 2016-000615-33 Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on progression of structural damage in the spine over two years in patients with ankylosing sp... 2021-02-25 due-trials
Reported results 2016-001777-33 EVALUATION OF CEREBRAL THROMBOEMBOLISM AFTER TAVR 2018-08-02 due-trials
Reported results 2016-002370-12 PROOF OF CONCEPT STUDY OF HYQVIA IN PATIENTS WITH IMMUNOGLOBULIN DEFICIENCY AND RECURRENT INFECTIONS WITH CHRONIC FATIGUE SYNDROME Proof of Concept Studie mit HyQvia bei Patienten mit Immunglobinma... 2018-08-27 due-trials
Reported results 2016-003175-22 Two-arm randomized phase II trial to assess the feasibility and efficacy of a treatment with Durvalumab a PDL1-Inhibitor plus Tremelimumab a CTLA-4- Inhibitor in combination with radiotherapy and a tr... 2023-07-14 due-trials
Reported results Terminated 2016-003802-14 Skin penetration of anti-inflammatory compounds in lesional compared to non-lesional skin of psoriasis patients Eindringen von entzündungshemmenden Wirkstoffen in erkrankter im Vergleich zu gesunde... 2017-07-10 due-trials
Reported results 2016-003828-23 A pilot open-label study to assess the efficacy and safety of tocilizumab (TCZ) in patients with active Schnitzler’s syndrome (SchS) 2019-04-10 due-trials
Reported results Terminated 2016-004825-17 A Proof-of-concept study to investigate the Efficacy of Telbivudine Over Placebo in patients with Parvovirus-associated Inflammatory Cardiomyopathy Eine Proof-of-concept-Studie, um die Wirksamkeit ... 2020-05-31 due-trials
Ongoing 2017-000058-21 Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy: a prospective randomized clinical trial Perkutaner Verschluss des... not-yet-due
Other 2017-000697-11 SPIRonolactone In the Treatment of Heart Failure - A double-blind, randomized, placebo-controlled, parallel group, interventional phase III study to evaluate the efficacy and safety of spironolactone ... not-yet-due
Reported results 2017-001262-25 A randomized, double-blind, placebo-controlled, proof-of-concept, multicenter, 16-week treatment study with a 16 week follow-up period to assess the exploratory efficacy and safety of Dupilumab (anti-... 2023-02-28 due-trials
Reported results 2017-001604-30 Safety, Tolerability and Efficacy of anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection after Kidney Transplantation - A Pilot Trial Sicherheit, Verträglichkeit und Aktivität des ... 2020-09-04 due-trials
Exempt 2017-003813-24 A phase I/IIa, prospective, mono-center, randomized, open labeled, controlled study to assess the safety and efficacy of applying Iloprost locally in the fracture site to promote bone healing in patie... not-yet-due
Completed, report not yet due 2017-004149-26 Effect of Metformin and Empagliflozin in insulin resistant patients with heart failure with reduced ejection fraction Effekt von Metformin und Empagliflozin bei insulinresistenten Patienten mit Her... 2024-02-28 not-yet-due
Reported results 2017-004458-41 A multicenter, randomized, double-blind, placebo-controlled, phase 2, 16-week treatment study with a 16 week follow-up period to assess the efficacy and safety of Dupilumab (anti-IL4Ra) in adult patie... 2021-07-07 due-trials
Reported results 2017-005151-83 INDUCTION AND MAINTENANCE OF MUCOSAL HEALING IN CROHN’S DISEASE WITH USTEKINUMAB IN CLINICAL PRACTICE 2023-01-30 due-trials
Reported results Terminated 2018-000492-32 Effects of antibiotics on micobiota, pulmonary immune response and incidence of ventilator-associated infections Einfluss von Antibiotikatherapien auf Mikrobiota, pulmonale Immunantwort und Inzide... 2023-02-17 due-trials
Reported results 2018-002938-20 Avelumab + Paclitaxel/ Ramucirumab as second line treatment in gastro-esophageal adenocarcinoma: a phase II trial of the AIO 2022-11-29 due-trials
Completed, report not yet due 2018-002947-27 Simvastatin add-on to Escitalopram in patients with comorbid obesity and major depression: A multicenter, randomized, double-blind, placebo-controlled trial Simvastatin als Zusatztherapie zur anti... 2024-06-06 not-yet-due
Completed, report not yet due 2018-004136-30 An Open-Label, Pilot Study to assess the effect of Lanadelumab on the clinical signs and symptoms of Hereditary angioedema with normal C1-inhibitor 2024-07-03 not-yet-due
Completed, report not yet due Terminated 2018-004254-22 Efficacy of Tofacitinib in Reduction of Inflammation Detected on MRI in Patients with Psoriatic ArthritiS PresenTing with Axial InvOlvement - a Randomized, Double-Blind, Placebo-Controlled, Multicen... 2024-05-02 not-yet-due
Completed, report not yet due 2019-001235-31 Factor XII-associated cold autoinflammatory syndrome (FACAS) linked to kallikrein-kinin pathology: Proof of concept treatment with Lanadelumab (DX-2930) 2024-06-10 not-yet-due
Other 2019-004223-20 Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment ... not-yet-due
Reported results Terminated 2020-001493-29 Charité trial of Cenicriviroc (CVC) treatment for COVID-19 patients 2022-01-06 due-trials
Reported results Terminated 2020-002282-33 Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT) 2021-10-06 due-trials
Reported results Terminated 2020-002510-40 A multicenter, randomized, double-blind, placebo-controlled, phase 2, 12-week treatment study followed by a 12 week open label phase and a 12-week follow-up period to assess the efficacy and safety of... 2021-07-07 due-trials
Exempt 2020-004102-63 AN OPEN LABEL, PHASE I/II STUDY TO INVESTIGATE THE USE OF VORAXAZE™ AS INTENDED INTERVENTION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND WITH IMPAIRED RENAL FUNCTION BEING TREATED WITH HIGH-D... 2024-10-01 not-yet-due
Reported results Terminated 2020-004399-16 Efficacy of erenumab in chronic cluster headache: A 10-week double-blind, randomized, placebo-controlled, multicentric trial 2023-09-27 due-trials
Other 2020-006144-18 Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418) Prospective, randomized, open, multicenter Phase III trial to investigate the effica... not-yet-due
Ongoing 2021-000319-21 Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study (ClonDoTrial) not-yet-due
Reported results Terminated 2021-000613-16 CCR1 antagonist treatment in patients hospitalized with COVID-19 A multi-centric, randomized, double-blind, and placebo-controlled clinical phase II trial CCR1 Antagonist Behandlung zur Therapie vo... 2023-03-20 due-trials
Completed, report not yet due 2021-000962-14 A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination with Standard Background Therapy in Participants with Moderate to Severe Systemic Lupus Erythematosus ... 2024-07-25 not-yet-due
Reported results 2021-001512-28 Immunogenicity of COVID-19 vaccines in medical staff and special risk populations 2021-12-30 due-trials
Completed, report not yet due 2021-002245-15 A low-interventional study to investigate the efficacy and safety of SARS-CoV-2 vaccines in patients with rheumatic diseases. Niedrig-interventionelle Studie zur Untersuchung der Effektivität und S... 2023-12-11 not-yet-due
Reported results 2021-002818-13 A Randomized, Double-blind, Placebo-controlled, Phase 2, 12-Week Treatment Study with a 10-Week Follow-up Period to Assess the Efficacy and Safety of Benralizumab (anti-IL5Rα) in Adult Patients with C... 2023-10-19 due-trials
Other 2021-004706-22 Imlifidase in ANCA-associated vasculitis Imlifidase in der Behandlung der ANCA-assoziierten Vaskulitis not-yet-due
Other 2021-005494-11 A parallel-group treatment, phase 2a, double-blind, placebo-controlled 2-arm study to show improvement of physical function in SF-36 (SF-36-PF) in participants treated with Vericiguat compared to plac... not-yet-due
Ongoing 2021-006031-25 Treatment of patients with Lichen planus with the JAK-Inhibitor Upadacitinib (Rinvoq®) – a mono-centered double-blinded placebo controlled randomized pilot study (investigator-initiated trial) Beh... not-yet-due
Ongoing 2021-006176-16 Definition of neuroimaging and laboratory biomarkers as possible predictors for treatment response to Galcanezumab in high-frequency episodic migraine (PREDICT) not-yet-due
Ongoing 2022-002681-32 Lumasiran in hyperoxalaemic patients on haemodialysis Lumasiran für Hämodialysepatienten mit Hyperoxalämie not-yet-due